See the DrugPatentWatch profile for cosentyx

Based on the provided information, there is no specific mention of risks associated with the use of live vaccines in conjunction with Cosentyx (secukinumab) [1][2]. However, it is generally recommended that individuals on biologic therapies, such as Cosentyx, consult with their healthcare provider prior to receiving any live vaccines [3]. This is because biologic therapies, which modify the immune system's response, may impact the effectiveness of vaccines and increase the risk of adverse reactions [3]. Therefore, it is crucial to have a personalized discussion with a healthcare provider to understand the potential risks and benefits [2].

Sources:
[1] DrugPatentWatch. Cosentyx (secukinumab). <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
[2] Cosentyx. COVID-19 Information. <https://www.cosentyx.com/all/covid19>
[3] Galloway JB, McElhaney JE. Influenza Vaccination in the Immunocompromised Host. Infectious Disease Clinics of North America. 2021;35(1):117-131. doi:10.1016/j.idc.2020.10.002. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>